Hema Kapoor MD. SM (NRM) Virology Section manager Bureau of laboratories
description
Transcript of Hema Kapoor MD. SM (NRM) Virology Section manager Bureau of laboratories
June 3, 2003 1
Hema Kapoor MD. SM (NRM)
Virology Section manager
Bureau of laboratories
Michigan Department of community Health
Lansing Michigan
Laboratory Issues and West Nile Virus
June 3, 2003 2
Laboratory Issues and West Nile Virus
ArbovirusesLaboratory DiagnosisInvestigation of 2002 WNV
outbreak in MichiganPlans for 2003-Lab perspective
June 3, 2003 3
The arboviruses
Arthropod-borne viruses(mosquitoes, sand-flies, fleas, ticks, lice, etc)
Enveloped RNA viruses -4 familiesFlaviviridae-WNV isolated in 1937 in
west Nile district of Uganda in Eastern Africa.
June 3, 2003 4
Arboviral encephalitides
Mosquitoeastern equine encephalitis (EEE)western equine encephalitis (WEE) St. Louis encephalitis (SLE) La Crosse (LAC) Ticks Powassan
June 3, 2003 5
WNV Transmission
Dead end host
Dead end host
New modes of transmission
June 3, 2003 6
Laboratory Issues and West Nile Virus
ArbovirusesLaboratory DiagnosisInvestigation of 2002 WNV
outbreak in MichiganPlans for 2003-Lab perspective
June 3, 2003 7
DAYS POST ONSETDAYS POST ONSET
1 2 3 4 5 6 7 8 9 10-5 -4 -3 -2 -1 0
IgM
IgG
ELISAELISAP/NP/N#pfu/ml#pfu/ml
WNviremia
150
illnessillness
Immune Response in WNV Infection
Ref: 4th National WNV Conf. 2003 www.cdc.gov
June 3, 2003 8
Laboratory Diagnosis of Human cases
• SpecimensCerebrospinal fluid (CSF)CSF and Serum combinationSera- Acute and Convalescent (obtained
at least 8 d and 22 d post onset respectively)
Least preferred single serum sample
Ref: Antibody Capture ELISA (IgM & IgG) Protocol. CDC Fort Collins, colorado
CDC Neutralization Test Protocol. CDC Fort Collins, colorado
June 3, 2003 9
Laboratory Diagnosis of Human cases contd
Ref: Antibody Capture ELISA (IgM & IgG) Protocol. CDC Fort Collins, colorado
CDC Neutralization Test Protocol. CDC Fort Collins, colorado
•Laboratory Tests
Capture enzyme-linked immunosorbent assay (MAC-ELISA-IgM).
Capture enzyme-linked immunosorbent assay (MAC-ELISA-IgG) and
Plaque Reduction Neutralization Test (PRNT)
June 3, 2003 10
Serological Testing Criteria at Michigan
CSF Paired sera(Ac. at least 8 days and conv at least 22 days post onset)
Single serum
•P/N ratio >/= 10 positive
•P/N 2-10 equivocal and requested for a serum sample.
•P/N ratio >/=5 presumptive. •P/N 2-5 equivocal.
•IgG Tests -A four-fold rise in titre to distinguish a recently acquired infection from a past infection.
•PRNT was performed on all specimens showing a four fold increase in IgG titer.
•P/N ratio- same as in paired sera.
•A convalescent serum requested on equivocals .
•PRNT To rule out the cross- reactions between WNV and other arbovirus infections (SLE, EEE and CGV).
•MAC-ELISA IgM performed in Singlet. Positive MAC-ELISA repeated in duplicate
June 3, 2003 11
West Nile Virus Nucleic Acid Amplification Tests (NAAT) Diagnostic Testing
Higher persistent levels of WNV RNA found in immuno-compromised patients
Improved sensitivity with better quality of diagnostic samples or virus concentration methods?
WNV RNA(-) results are meaningless
June 3, 2003 12
Identifying viremic / antibody negative “window phase” patients
Low levels WNV RNA found in clinically ill, immuno- competent patients (i. e., WN fever)
West Nile Virus Nucleic Acid Amplification Tests (NAAT) Diagnostic Testing
June 3, 2003 13
Laboratory Issues and West Nile Virus
ArbovirusesLaboratory DiagnosisInvestigation of 2002 WNV
outbreak in MichiganPlans for 2003-Lab perspective
June 3, 2003 14June 3, 2003June 3, 2003
55
94
240
266
319
270 270289
333
193
144
231
7055
422311 16 20 20
91
61 65
38 38
12 16 14 620
0
112
0
50
100
150
200
250
300
350
11-Aug
18-Aug
25-Aug
01-Sep
08-Sep
15-Sep
22-Sep
29-Sep
06-Oct
13-Oct
20-Oct
27-Oct
03-Nov
10-Nov
17-Nov
24-Nov
Weeks
Nu
mb
ers
total positive
Total Specimens (Jan, 02-Dec, 02)-2910
Weekly WNV Testing (Aug-Nov 02)
June 3, 2003 15
Virology section and intersection staff worked collectively 6 days a week
How we handled the 2002 outbreak in the laboratory ?
Triaged the samples
June 3, 2003 16
CSF at MDCH 0 day
IgM ELISA 1st Run Report
via EPIC
NegNotificationVia EPIC toSubmitter,
LDH & EPI 4 day
Pos
Investigation
Confirmed positive reportsVia
EPIC 5 6day
IgM ELISA 2nd Run
pos
Quantity Sufficient
pos
Equivocal
Request a convalescent serum sample
QNS
To report a Probable case
request a serum sample
June 3, 2003 17
Convalescent serumNo
PRNT on acute serum (Convalescent sample not possible )
Pos
Acute Serum at MDCH (0day)
NegIgM ELISA 1st runReport Via EPIC
No 4x increase
4x rise in titer
Yes
PRNT on pair
Confirmed positive reportsVia
EPIC
Arboviral
Panel
IgM ELISA 2nd run
Reported a presumptive positive (LAB) & probable case (EPI)Via EPIC with a request for a convalescent serum
Pos
Pos
Pos
Investigation
Notification via EPIC to
Sub, LHD & EPI
June 3, 2003 18
Single serum with documented CNS symptoms or paired sera without 4X increase in titer
IgM ELISA (+) PRNT (-)
Test for SLE, EEE and CGV
Probable WNV Case
Neg
Yes
Single serum collected too early (0-8 d) post onset
No
Paired sera
Yes
No WNV Case
June 3, 2003 19
Laboratory Issues and West Nile Virus
ArbovirusesLaboratory DiagnosisInvestigation of 2002 WNV
outbreak in MichiganPlans for 2003-Lab perspective
June 3, 2003 20
Plans for 2003
Human Surveillance No triaging of samples Test whole panel Two LT positions in virology for WNV testing Cross training IgM capture ELISA testing on CSF and Paired serum Attempt culture on for WNV
June 3, 2003 21
Issues with Persistence of IgM antibodies
Getting Ready for summer of 2003 contd
June 3, 2003 22
Longevity of Human WN Virus-Reactive IgM in Serum
Days P.I.
N Positive MAC-ELISA Total (%)
Ave. P/N (Range)Positive
(%)Equivocal
200 22 13 (60) 4 17 (77) 6.0 (3.0-10.8)
300-400
21 9 (43) 2 11 (52) 4.0 (31.-6.5)
500 12 5 (42) 2 6 (60) 5.0 (3.1-6.9)
Ref: 4th National WNV Conf. 2003 www.cdc.gov
June 3, 2003 23
Hold and request for the Convalescent serum
PRNT on acute serum
Pos
No
CNS symptoms +
Approval of Virology Lab Manger
Neg IgM ELISA 1st Run
IgM ELISA 2nd RunPos
Pos
Report
Acute Serum at MDCH
2003 Testing
Yes
4x rise in titer
PRNT (IgG) on pair
Confirmed positive reportsVia
EPIC
No 4x increaseArboviral
Panel
June 3, 2003 24
Persistence of IgM antibodies
In CSF-No studies
Published-47d
MDCH observations-Three cases with igM positive
110d
141d
199d
June 3, 2003 25
To Sum Up……. Human Cases ?
Over wintering
adult Culex mosquitoes